Xhale Inc - Product Pipeline Analysis, 2018 Update

Xhale Inc - Product Pipeline Analysis, 2018 Update


  • Products Id :- GDME2338PD
  • |
  • Pages: 32
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Xhale Inc (Xhale) is a medical technology company that develops and commercializes patient-centric monitoring solutions for the healthcare industry. The company offers platforms such as SMART and assurance platforms. Its products include therapeutic drug monitoring, metabolic pathway assessment and monitoring, SMART for pharmaceutical supply chain integrity assessment of gastric emptying, hypovolemic shock detection, oral glucose tolerance test pharmacodynamic anesthesia administration, glucose monitoring, and breath-based health monitors, among others. The company's SMART product is the technology that monitors drug medication adherence in real-time. Its Assurance pulse oximetry sensor, is a single-point-of-contact sensor that can monitor critical cardiorespiratory parameters under challenging conditions for patients. Xhale is headquartered in Gainesville, Florida, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Xhale Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Xhale Inc Company Overview 4

Xhale Inc Company Snapshot 4

Xhale Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Xhale Inc-Pipeline Analysis Overview 7

Xhale Inc-Key Facts 7

Xhale Inc-Major Products and Services 8

Xhale Inc Pipeline Products by Development Stage 9

Xhale Inc Pipeline Products Overview 11

Assurance Hypovolemic Shock Detection Monitor 11

Assurance Hypovolemic Shock Detection Monitor Product Overview 11

Assurance Multi-sense Sensor 12

Assurance Multi-sense Sensor Product Overview 12

Assurance PCA Guardian 13

Assurance PCA Guardian Product Overview 13

Assurance Pharmacodynamic Anesthesia Administration Monitor 14

Assurance Pharmacodynamic Anesthesia Administration Monitor Product Overview 14

Breath-Based Glucose Monitor 15

Breath-Based Glucose Monitor Product Overview 15

Oral Glucose Tolerance Test 16

Oral Glucose Tolerance Test Product Overview 16

Respiratory Oximeter 17

Respiratory Oximeter Product Overview 17

SMART Assessment-Gastric Emptying 18

SMART Assessment-Gastric Emptying Product Overview 18

SMART Metabolic Pathway Assessment And Monitoring 19

SMART Metabolic Pathway Assessment And Monitoring Product Overview 19

SMART Therapeutic Drug Monitoring 20

SMART Therapeutic Drug Monitoring Product Overview 20

XSensor Pro-Propofol Monitor 21

XSensor Pro-Propofol Monitor Product Overview 21

Xhale Inc-Key Competitors 22

Xhale Inc-Key Employees 23

Xhale Inc-Locations And Subsidiaries 24

Head Office 24

Recent Developments 25

Xhale Inc, Recent Developments 25

Sep 22, 2015: Xhale Submits Biomarker Qualification Package to FDA for Medication Adherence Monitoring Tool 25

Mar 18, 2015: Xhale Assurance Announces FDA Approval of its Second Generation Nasal Alar SpO2 Sensor 25

Oct 11, 2013: New technology "right under our nose" -Assurance Alar One-Sense to be highlighted at annual ASA 26

May 31, 2011: Xhale Received U.S. Patent For Non-invasive Monitoring Of Blood Glucose Using Exhaled Breath 27

Jan 04, 2011: XI Appoints Craig Davenport As CEO And Member Of Board 27

Jul 01, 2008: Xhale To Open New Corporate Headquarters 28

Mar 04, 2008: Xhale, Inc. To Present At The 3rd International Conference On HIV Treatment Adherence 28

Jan 30, 2008: Xhale Receives Phase 1 SBIR Grant To Develop A Breath-Based Medication Adherence Monitoring System 28

May 11, 2006: Xhale Diagnostics Licenses Breath-Based Diagnostic Technology From UF 28

Appendix 29

Methodology 29

About GlobalData 32

Contact Us 32

Disclaimer 32

List of Figures

Xhale Inc Pipeline Products by Equipment Type 5

Xhale Inc Pipeline Products by Development Stage 9

List of Tables

Xhale Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Xhale Inc Pipeline Products by Equipment Type 5

Xhale Inc Pipeline Products by Indication 6

Xhale Inc, Key Facts 7

Xhale Inc, Major Products and Services 8

Xhale Inc Number of Pipeline Products by Development Stage 9

Xhale Inc Pipeline Products Summary by Development Stage 10

Assurance Hypovolemic Shock Detection Monitor-Product Status 11

Assurance Hypovolemic Shock Detection Monitor-Product Description 11

Assurance Multi-sense Sensor-Product Status 12

Assurance Multi-sense Sensor-Product Description 12

Assurance PCA Guardian-Product Status 13

Assurance PCA Guardian-Product Description 13

Assurance Pharmacodynamic Anesthesia Administration Monitor-Product Status 14

Assurance Pharmacodynamic Anesthesia Administration Monitor-Product Description 14

Breath-Based Glucose Monitor-Product Status 15

Breath-Based Glucose Monitor-Product Description 15

Oral Glucose Tolerance Test-Product Status 16

Oral Glucose Tolerance Test-Product Description 16

Respiratory Oximeter-Product Status 17

Respiratory Oximeter-Product Description 17

SMART Assessment-Gastric Emptying-Product Status 18

SMART Assessment-Gastric Emptying-Product Description 18

SMART Metabolic Pathway Assessment And Monitoring-Product Status 19

SMART Metabolic Pathway Assessment And Monitoring-Product Description 19

SMART Therapeutic Drug Monitoring-Product Status 20

SMART Therapeutic Drug Monitoring-Product Description 20

XSensor Pro-Propofol Monitor-Product Status 21

XSensor Pro-Propofol Monitor-Product Description 21

Xhale Inc, Key Employees 23

Glossary 31

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Imalux Corporation

FMI Medical Systems Inc

SimpleChoice

IMIX Americas

Xhale Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 51750
Site License
USD 1500 INR 103500
Corporate User License
USD 2250 INR 155250

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com